It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-014.mrc:168185098:4636
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-014.mrc:168185098:4636?format=raw

LEADER: 04636cam a22004815a 4500
001 6984699
005 20221130200511.0
008 080423t20092009nyua b 001 0 eng
010 $a 2008938672
015 $aGBA875747$2bnb
016 7 $a014640962$2Uk
020 $a9780387798370 (hbk.)
020 $a0387798374 (hbk.)
035 $a(OCoLC)ocn227032651
035 $a(OCoLC)227032651
035 $a(NNC)6984699
035 $a6984699
040 $aUKM$cUKM$dBTCTA$dBAKER$dYDXCP$dOCLCG$dCUS$dNNC-M$dOrLoB-B
082 04 $a618.929$222
245 00 $aHot topics in infection and immunity in children.$nV /$cAdam Finn, Nigel Curtis, Andrew J. Pollard, editors.
246 3 $aHot topics in infection and immunity in children.$n5
260 $aNew York ;$aLondon :$bSpringer,$c[2009], ©2009.
300 $axiv, 264 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in experimental medicine and biology ;$vv. 634
504 $aIncludes bibliographical references and index.
505 00 $tShiga-Toxin Producing Escherichia coli and the Hemolytic Uremic Syndrome: What Have We Learned in the Past 25 Years? /$rChristina K. Ahn, Nicholas J. Holt and Phillip I. Tarr -- $tGlobal Epidemiology of Pneumococcal Disease - New Prospects for Vaccine Control /$rVinicius C. Antao and William P. Hausdorff -- $tCurrent Concepts of the Pathogenesis of RSV Bronchiolitis /$rLouis Bont -- $tHow Can We Eradicate Pertussis /$rJames D. Cherry -- $tRecognition and Management of Encephalitis in Children /$rJames D. Cherry -- $tMicrobiology and Management of Pleural Empyema /$rJulia Clark -- $tPneumococcal Conjugate Vaccines Probe Studies: The Solution Points to the Problem /$rRon Dagan -- $tNew Findings in Primary Immunodeficiency /$rAndrew R. Gennery and Andrew J. Cant -- $tRoutine Use of Iufluenza Vaccine /$rDavid Isaacs -- $tChallenges in the Evaluation and Management of Bone and Joint Infections and the Role of New Antibiotics for Gram Positive Infections /$rSheldon L. Kaplan -- $tThe Significance of Serotype Replacement for Pneumococcal Disease and Antibiotic Resistance /$rKeith P. Klugman -- $tChildhood Intra-thoracic Tuberculosis /$rBen J. Marais -- $tThe Antibiotic Pipeline in Pediatrics /$rGeorge H. McCracken -- $tPaediatric Drug Development and Clinical Trials /$rE. David G. McIntosh -- $tInfluenza in Pregnancy: The Case for Prevention /$rShelly McNeil, Beth Halperin and Noni MacDonald -- $tFebrile Neutropeniain Children with Cancer /$rStephune Paulus and Simon Dobson -- $tThe PANDAS Syndrome /$rMichael E. Pichichero -- $tFeverin the Returned Paediatric Traveller /$rF. Andrew I. Riordan -- $tMolecular Diagnostics of Primary Immunodeficiencies: Benefits and Future Challenges /$rMirjam van der Burg, Menno C. van Zelm and Jacques J.M. van Dongen -- $tHuman Genetic Resistance to Malaria /$rThomas N. Williams.
520 1 $a"Course covers topics in infectious diseases in children and is intended for Pediatric Infectious disease trainees, trainers, and all those who manage children with infections." "This conference is being supported by several societies and is sponsored by several pharmaceutical companies, such as Aventis, Baxter, Chiron Vaccines, Wyeth, etc." "This book is written for researchers and professionals in the areas immunology, infectious disease, pharmaceutical sciences, virology, microbiology, and pathobiology."--BOOK JACKET.
650 0 $aInfection in children.$0http://id.loc.gov/authorities/subjects/sh85066077
650 0 $aCommunicable diseases in children.$0http://id.loc.gov/authorities/subjects/sh85029023
650 0 $aChildren$xDiseases$xImmunological aspects.
650 12 $aInfections$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D007239Q000188
650 22 $aInfections$ximmunology.$0https://id.nlm.nih.gov/mesh/D007239Q000276
650 22 $aBacterial Infections$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D001424Q000188
650 22 $aBacterial Infections$ximmunology.$0https://id.nlm.nih.gov/mesh/D001424Q000276
650 22 $aVirus Diseases$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D014777Q000188
650 22 $aVirus Diseases$ximmunology.$0https://id.nlm.nih.gov/mesh/D014777Q000276
700 1 $aFinn, Adam,$d1959-$0http://id.loc.gov/authorities/names/n2004119339
700 1 $aCurtis, Nigel.$0http://id.loc.gov/authorities/names/no2008184317
700 1 $aPollard, Andrew J.$0http://id.loc.gov/authorities/names/n96802578
830 0 $aAdvances in experimental medicine and biology ;$vv. 634.$0http://id.loc.gov/authorities/names/n42001229
852 00 $boff,hsl$hRJ401$i.H68 2009